Sexually transmitted infections in people with multidrug-resistant HIV.
Journal
AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219
Informations de publication
Date de publication:
01 12 2023
01 12 2023
Historique:
medline:
16
11
2023
pubmed:
15
11
2023
entrez:
15
11
2023
Statut:
ppublish
Résumé
Retrospective, cohort analysis including people with four-class drug-resistant HIV. Bacterial sexually transmitted infections (STIs) had an incidence of 1.3/100-person-years-of-follow-up (PYFU) in men (3.5/100-PYFU in MSM) whereas no STIs were diagnosed in women. The occurrence of STIs in this fragile population might be related to the achievement of good HIV infection control; however, given the remaining risk of virological failure and possible transmission of a multidrug-resistant virus, STI prevention counselling and HIV viremia monitoring should be prioritized.
Identifiants
pubmed: 37965740
doi: 10.1097/QAD.0000000000003690
pii: 00002030-202312010-00020
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2425-2430Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Hsu RK, Fusco JS, Henegar CE, Vannappagari V, Clark A, Brunet L, et al. Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes. BMC Infect Dis 2023; 23:91.
Galli L, Parisi MR, Poli A, Menozzi M, Fiscon M, Garlassi E, et al. PRESTIGIO Study Group. Burden of disease in PWH harboring a multidrug-resistant virus: data from the PRESTIGIO Registry. Open Forum Infect Dis 2020; 7:ofaa456.
Clemente T, Caccia R, Galli L, Galli A, Poli A, Marchetti GC, et al. for the PRESTIGIO Study Group. Inflammation burden score in multidrug-resistant HIV-1 infection. J Infect 2023; 86:453–461.
World Health Organization. Global health sector strategy on sexually transmitted infections 2016-2021: toward ending STIs. Available at: https://apps.who.int/iris/handle/10665/246296. [Accessed 25 April 2023]
Cole SR, Napravnik S, Mugavero MJ, Lau B, Eron JJ Jr, Saag MS. Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden. Am J Epidemiol 2010; 171:198–205.
Cingolani A, Zona S, Girardi E, Cozzi-Lepri A, Monno L, Quiros Roldan E, et al. Community-Oriented Study Group of the Icona Foundation Study Group. Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort. HIV Med 2015; 16:412–420.
Geretti AM, Mardh O, de Vries HJC, Winter A, McSorley J, Seguy N, et al. Sexual transmission of infections across Europe: appraising the present, scoping the future. Sex Transm Infect 2022; sextrans-2022-055455.
Gravett RM, Cleveland JD, Overton ET, Marrazzo J. Bacterial sexually transmitted infection incidence among southern men who have sex with men with human immunodeficiency virus in the treatment as prevention era, 2014-2019. Clin Infect Dis 2022; 75:1446–1448.
Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, PARTNER Study Group, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA 2016; 316:171–181.
Cohen MS, Council OD, Chen JS. Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy. J Int AIDS Soc 2019; 22: (Suppl 6): e25355.